Autoimmune Liver Diseases Exploratory Research Award

Application Deadline
Award Amount
Award Term
One year
Award Type
Clinical / Translational / Outcomes Research
Basic Science Research
Autoimmune Hepatitis-Related Research
Primary Biliary Cholangitis (PBC)-Related Research
Primary Sclerosing Cholangitis (PSC)-Related Research
Career Level
Pre-Doctoral / Graduate
Fellows / Postdocs
Junior Faculty

View the 2024 Request for Applications [PDF].


The purpose of this award is to provide supplementary funding during the pilot/exploratory phase of basic, translational or clinical research projects in autoimmune liver disease (e.g., autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis) in preparation for future grant applications by the recipient. Projects should address focused research questions pertaining to the pathogenesis, diagnosis, management, or outcome of autoimmune liver diseases in children and adults.

Notice of Special Interest

Additional dedicated funding to advance research activities in autoimmune hepatitis is available for the 2024 Awards cycle. Applications in autoimmune hepatitis are encouraged in all early to mid-career research award categories and the Pilot and Autoimmune Exploratory Research Award categories.

  • Eligibility
  • Award Details
  • Selection Criteria
  • How to Apply
  • Application Resources


In order to be eligible for this award, the applicant must adhere to the following guidelines:

  1. The applicant must:
    • Be at the pre-doctoral/graduate level, post-doctoral level, or junior faculty within the first five years of their first faculty appointment (including prior appointments in universities outside of North America) at the start of the award (faculty appointment starting no earlier than July 1, 2019).
    • Be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period.
    • Be able to devote at least 20% effort to research activities related to this award.
    • Be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research. Individuals employed at the NIH, FDA, and CDC are not eligible to apply.
    • Have a mentor or co-mentor who is an AASLD member in good standing at the time of application and for the duration of the award period.
  2. The proposed project must: 
    • Focus on research pertaining to the pathogenesis, diagnosis, management, or outcome of autoimmune liver diseases in children and/or adults.
    • Not be an established project with alternate funding.
    • Be conducted at the sponsoring institution within the United States, Canada or Mexico.
  3. Application limits:
    • There is no restriction on the number of applicants an institution can sponsor each cycle, but only one applicant may be funded per distinct department within each institution in this award category.
    • Applicants may only apply for one AASLD Foundation research award per calendar year. Eligible applicants in this category may also apply for the AASLD Foundation Advanced/Transplant Hepatology Award in the same calendar year. 


Questions? Contact

Return to Current Funding Opportunities



The 2024 Autoimmune Liver Diseases Exploratory Research Award program is made possible through a generous anonymous contribution in support of AILD research, and independent grants and unrestricted donations from AASLD and donors to the AASLD Foundation.